Cryoballoon ablation without use of contrast for the treatment of paroxysmal atrial fibrillation
, 1, 1, 2, 1, 1, 2
Abstract
Background: Cryoballoon ablation (CBA) for atrial fibrillation (AF) is usually preceded by demonstrating pulmonary vein (PV) occlusion using contrast. The aim of the study was to determine efficacy and safety of a simplified protocol for CBA performed without demonstrating PV occlusion and compare achieved results with conventional CBA. Methods: Paroxysmal AF patients undergoing a first-time CBA were prospectively included. In the non-contrast (NC) group CBA was performed using standardized protocol without demonstrating PV occlusion. In the conventional contrast (CC) group ablations were performed after confirmation of PV occlusion. Results: The NC and CC groups comprised 51 and 22 patients, respectively. PVI according to the group assignment was achieved in 34 (67%) and 21 (95.5%) patients from the NC and CC groups, respectively (p < 0.001). In the NC group, 184 (90%) out of 204 veins were isolated without venography. There were no differences between the NC and CC groups in terms of procedure duration (89.7 ± 22.6 vs. 90.0 ± 20.6 min; p = 0.7) and fluoroscopy time (15.3 ± 6.3 vs. 15 ± 4.5 min; p = 0.8). In the NC group, the use of contrast was significantly lower compared to the CC group (4.9 ± 10.1 vs. 19.4 ± 8.6 mL, p < 0.001). There were no serious adverse events in both groups. A 1-year freedom from AF was achieved in 73.5% and 71.5% of patients from the NC and CC groups, respectively (p = 1). Conclusions: Cryoballoon ablation without demonstrating vein occlusion with contrast is safe and feasible. Proposed simplified approach enables isolation of the vast majority of pulmonary veins with a significant reduction in the amount of contrast used.
Keywords: atrial fibrillationcryoballoon ablationpulmonary vein isolation
References
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
- Chun KRJ, Schmidt B, Metzner A, et al. The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009; 30(6): 699–709.
- Metzner A, Reissmann B, Rausch P, et al. One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2014; 7(2): 288–292.
- Kuck KH, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016; 374(23): 2235–2245.
- Schmidt M, Dorwarth U, Andresen D, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2014; 25(1): 1–7.
- Mugnai G, Chierchia GB, de Asmundis C, et al. Comparison of pulmonary vein isolation using cryoballoon versus conventional radiofrequency for paroxysmal atrial fibrillation. Am J Cardiol. 2014; 113(9): 1509–1513.
- Su W, Kowal R, Kowalski M, et al. Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm. 2015; 12(7): 1658–1666.
- Knecht S, Kühne M, Altmann D, et al. Anatomical predictors for acute and mid-term success of cryoballoon ablation of atrial fibrillation using the 28 mm balloon. J Cardiovasc Electrophysiol. 2013; 24(2): 132–138.
- Saitoh Y, Ströker E, Irfan G, et al. Fluoroscopic position of the second-generation cryoballoon during ablation in the right superior pulmonary vein as a predictor of phrenic nerve injury. Europace. 2016; 18(8): 1179–1186.
- Kühne M, Knecht S, Spies F, et al. Cryoballoon ablation of atrial fibrillation without demonstration of pulmonary vein occlusion-the simplify cryo study. Front Cardiovasc Med. 2021; 8: 664538.
- Suzuki A, Fujiwara R, Asada H, et al. Peri-balloon leak flow velocity assessed by intra-cardiac echography predicts pulmonary vein electrical gap - intra-cardiac echography-guided contrast-free cryoballoon ablation. Circ J. 2022; 86(2): 256–265.
- Maalouf J, Whiteside HL, Pillai A, et al. Reduction of radiation and contrast agent exposure in a cryoballoon ablation procedure with integration of electromagnetic mapping and intracardiac echocardiography: a single center experience. J Interv Card Electrophysiol. 2020; 59(3): 545–550.
- Hasegawa K, Miyazaki S, Kaseno K, et al. Pressure-guided second-generation cryoballoon pulmonary vein isolation: prospective comparison of the procedural and clinical outcomes with the conventional strategy. J Cardiovasc Electrophysiol. 2019; 30(10): 1841–1847.
- Alyesh D, Venkataraman G, Stucky A, et al. Acute safety and efficacy of fluoroless cryoballoon ablation for atrial fibrillation. J Innov Card Rhythm Manag. 2021; 12(2): 4413–4420.
- Miyama H, Takatsuki S. Less invasive ablation of atrial fibrillation achieved by contrast-free cryoballoon ablation. Circ J. 2022; 86(2): 266–267.
- Avitall B, Kalinski A, Kocheril GS, et al. Novel dyeless and fluoro-less approach to cryoballoon pulmonary vein occlusion assessment. Heart Rhythm. 2017; 14(8): 1241–1246.
- Makino Y, Mizutani Y, Yamashita D, et al. Cryoballoon ablation for atrial fibrillation without the use of a contrast medium: a combination of the intracardiac echocardiography and pressure wave monitoring guided approach. Heart Vessels. 2022; 37(5): 765–774.
- Schillaci V, Stabile G, Arestia A, et al. Fluoroscopy and contrast media use in cryoballoon ablation of atrial fibrillation using a novel imaging system. Heart Vessels. 2022; 37(1): 115–120.
- Cauti FM, Solimene F, Stabile G, et al. Occlusion tool software for pulmonary vein occlusion verification in atrial fibrillation cryoballoon ablation. Pacing Clin Electrophysiol. 2021; 44(1): 63–70.
- Creta A, Kanthasamy V, Schilling RJ, et al. First experience of POLARx™ versus Arctic Front Advance™: an early technology comparison. J Cardiovasc Electrophysiol. 2021; 32(4): 925–930.
- Stachyra M, Tarkowski A, Szczasny M, et al. Practical approach to the cryoballoon-ablation mapping technique in atypical pulmonary vein anatomy. Kardiol Pol. 2021; 79(2): 213–214.
